脉冲场切除肺静脉隔离后急性心膜炎的风险 肺静脉隔离
Juliana Pérez-Pinzón1, Shu Yang1, Timothy Maher1
1Division of Cardiovascular Medicine, Harvard-Thorndike Arrhythmia Institute, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Heart rhythm O2
|September 8, 2025
概括
脉冲场移除 (PFA) 肺静脉隔离 (PVI) 后的后移除心膜炎 (PAP) 发生率与射频移除 (RFA) PVI相似. 对于PAP的风险因素在两种废弃技术中保持一致.
科学领域:
- 心脏病学 心脏病学
- 电力生理学 电力生理学
- 医疗器械 医疗器械
背景情况:
- 肺静脉隔离手术 (PVI) 后的已知并发症之一是后发性心膜炎 (PAP).
- 射频除 (RFA) 是PVI的一种常见方法,但可以导致PAP.
- 脉冲场切除 (PFA),一种较新的非热切除技术,被假设具有较低的PAP率.
研究的目的:
- 为了前性地评估PFA指导PVI后的PAP发病率.
- 为了比较 PFA 和 RFA PVI 程序之间的 PAP 率.
- 在接受PVI的患者中识别与PAP相关的风险因素.
主要方法:
- 一项前性研究涉及322名接受PFA PVI的患者和1750名接受RFA PVI的患者的回顾性队列.
- 收集关于PAP发病率,报告时间,管理和结果的数据.
- 后勤回归分析以确定与PAP发展相关的因素.
主要成果:
- 急性心膜炎的发病率在PFA后为4.3%,在RFA后为3.4% (P = .41),没有显著差异.
- PAP呈现的中位时间为PFA的4天,而RFA的1天 (P = .12).
- 女性性别和阻塞性睡眠呼吸暂停与增加PAP风险有关,而先前的切除和年龄较大降低了风险.
结论:
- 与最初的预期相反,PFA PVI与PAP率相关,与RFA PVI相比.
- 在PFA和RFAPVI之间,发展PAP的危险因素似乎很相似.
- 可能需要进一步的研究来理解和减轻PFA技术的PAP风险.
相关概念视频
Pericarditis II: Clinical Features and Diagnostic Tests
291
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
291
Cardiac Catheterization II: Right Heart Catheterization
845
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
845
Pericarditis I: Introduction
338
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
338
Pericarditis IV: Nursing Management
324
Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
324
Pericarditis III: Medical Management
316
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
316


